Catherine Lord is distinguished professor of psychiatry and education at the University of California, Los Angeles. She specializes in diagnosis, social and communication development, and intervention in autism.
Catherine Lord
Director, Center for Autism and the Developing Brain
Weill Cornell Medicine
From this contributor
Your questions about the Lancet Commission and ‘profound autism,’ answered
Tony Charman and Catherine Lord answer questions from Spectrum’s webinar on the Lancet Commission’s recommendations for autism research.
Your questions about the Lancet Commission and ‘profound autism,’ answered
By
Spectrum
15 February 2022 | 6 min read
Catherine Lord: Lessons from a storied career in autism research
Catherine Lord's career has been defined by relationships: with mentors, protegees and, above all, with autistic people and their families.
Catherine Lord: Lessons from a storied career in autism research
By
Catherine Lord
3 December 2019 | 6 min read
Measures of success for adults with autism need to mature
As children with autism grow into adults, the challenge is in measuring the skills that matter most in their daily lives.
Measures of success for adults with autism need to mature
By
Catherine Lord
17 November 2015 | 5 min read
Optimal outcome
Some children classified as having autism outgrow their diagnosis, but it’s not yet clear why this group does better, says Cathy Lord.
Autism and the arts: “Lucy” captures disorder‘s complexity
Itʼs not often that movies, books and plays represent science accurately, or with a true and empathetic understanding of its complexity.
Autism and the arts: “Lucy” captures disorder‘s complexity
By
Catherine Lord
28 January 2008 | 5 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read